Back

The COMPASS trial: a new paradigm in lower extremity artery disease?

25 August 2018 (11:22 - 11:45)
Organised by:
Congress Presentation Part of: Essentials in PAD: New evidence since the PAD guidelines - Will they change our practice? Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Otavio Berwanger

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Antidiabetic agents in lower extremity artery disease: save the patient? Save the limb?
Professor M. Vrsalovic (Zagreb, HR)
Slides Video
Presentation thumbnail
Lipid lowering therapy in peripheral vascular disease. Which targets? Which drugs?
Doctor I. Desormais (Limoges, FR)
Slides Video
Presentation thumbnail
Revascularisation in peripheral artery disease
Professor M. Venermo (Helsinki, FI)
Slides Video

Access the full session

Session thumbnail
Essentials in PAD: New evidence since the PAD guidelines - Will they change our practice?

The Event

Event poster

ESC Congress 2018

25 August 2018 11:22 CET
You may be interested in
thumbnail
Congress Presentation
Navigating lower limb PAD diagnosis and treatment
2 September 2024
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Presentation
Efficacy of colchicine on major limb and cardiovascular adverse events in peripheral artery disease: a pilot meta-analysis
15 March 2025
thumbnail
Congress Presentation
Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources